ClinicalTrials.gg
RecruitingNCT06289686Updated Jul 13, 2026

Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation

A Phase 4 interventional study of Rotator cuff repairs with BioEnthesis augmentation and Rotator cuff repairs without BioEnthesis augmentation in Rotator Cuff Tears, Rotator Cuff Injuries and Surgery, sponsored by Brooke Army Medical Center. Recruiting at 5 sites in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by Brooke Army Medical Center · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jul 2023, registered Feb 2024).
  • Started Jul 2023; still recruiting 3 years 3 months later.
Phase
Phase 4
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Rotator cuff (RC) injuries are particularly prevalent, difficult to repair, and attachment between the bone and tendon is notoriously difficult to achieve. The most common method and current standard of care (SOC) for reattaching connective tissues (e.g., ligaments, tendons) to bone typically involves suture anchor-based techniques, but this is fraught with problems. More specifically, re-tearing of the connective tissue after this procedure occurs in 30-60% of cases, and can be even higher in patients who engage in smoking, have a diagnosis of diabetes, etc. To address these clinical challenges, Sparta Biopharma Inc. (Sparta) developed a unique technology, called BioEnthesis, to improve the connection between the tendon and bone. Pre-clinical in vivo studies demonstrated that the biphasic bovine cancellous matrix regenerated at the bone-soft tissue interface-thereby leading to high structural integrity and will likely lead to reduced re-tear rates over time. The investigators hypothesize that patients in this interventional cohort will experience enhanced mobility, reduced pain, and less re-tears after RC procedures versus a standard suture anchor-based repair.

02

Conditions studied

  • Rotator Cuff Tears
  • Rotator Cuff Injuries
  • Surgery

Browse trials for

03

In context

Rotator Cuff Injuries

631 studies on the registry are indexed under Rotator Cuff Injuries; 156 are open to participants now.

This study's planned enrollment of 100 is above the median of 60 across 456 interventional studies indexed under Rotator Cuff Injuries.

Browse Rotator Cuff Injuries studies →

Lead sponsor

Brooke Army Medical Center is the lead sponsor of 94 studies on the registry; 11 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 2 (25%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • DEERS-eligible
  • Adults, between the ages of 18-65 (inclusive)
  • Presenting with a rotator cuff tear that is reparable surgically (a reparable tear is defined as tear of the RC where it is possible to bring the retracted tendon edge back to the greater tuberosity of the humerus under minimal tension)
  • Ability to undergo surgery to repair rotator cuff tear
  • Willingness to commit to study procedures including study intervention and a 12-month follow-up
  • Fluency in speaking, reading, comprehending English
  • 1-2 tendon full thickness reparable RC tear (full thickness tear is defined as a tear that involves the majority of supraspinatus and less than half of the infraspinatus under minimal tension, with no subscapularis involvement beyond the upper border)
  • Patients who have high-grade partial thickness tears where the surgeon elects to complete the tear during surgery before repairing the tendon(s)

Exclusion criteria

Exclusion Criteria:

  • Previous shoulder surgery (excluding acromioplasty or diagnostic arthroscopy)
  • Inability to receive an MRI
  • Current (within the past 6 months) tobacco user
  • Unwilling to remain tobacco free for the duration of the study
  • Current lower limb injuries requiring walking assist devices such as crutches and walkers
  • Diagnosed with systemic arthritis
  • Significant neck pathology
  • Active joint or systemic infection
  • Currently enrolled, or plans to enroll, in another clinical trial during this study (that would affect the patient's safety or results of this trial)
  • Significant muscle paralysis of the shoulder girdle
  • Currently pregnant or plans to become pregnant during this study
  • Inability of the surgeon to repair the tear with remaining defect no greater than 10 mm in diameter
  • Inability of the surgeon to repair the tear with less than 1cm of medialization
  • Evidence of other significant shoulder pathology (such as Grade III osteoarthritis)
  • Has a history of alcohol abuse, illicit drug use, significant mental illness, physical dependence to any opioid, or drug abuse or addiction
  • Major medical illness that would preclude undergoing surgery
  • Major psychiatric illness or developmental handicap
  • Goutallier III classification and above
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    BioEnthesis

    Allogenic, acellular, biphasic allograft (BioEnthesis)

    Procedure: Rotator cuff repairs with BioEnthesis augmentation

  • Active comparator
    Standard of Care

    Standard rotator cuff repair (suture and anchor based technique)

    Procedure: Rotator cuff repairs without BioEnthesis augmentation

Interventions

  • ProcedureRotator cuff repairs with BioEnthesis augmentation

    Rotator cuff repair using BioEnthesis allograft patch

  • ProcedureRotator cuff repairs without BioEnthesis augmentation

    Rotator cuff repair using standard of care sutures and anchors

06

What researchers measure

Primary outcomes

  1. Rates of re-tear

    Re-tear rates following rotator cuff repair using BioEnthesis versus standard of care. Assessed with (1) 12-month follow-up shoulder MRI and assigning Sugaya Classification, and (2) adverse events evaluation at each follow-up timepoint

    Time frame: Post-operation at 3-months, 6-months, and 12-months

Secondary outcomes

  1. Change in the Visual Analogue Scale (VAS) from before surgery to after surgery

    A tool used to help a person rate the intensity of certain sensations and feelings, such as pain. The visual analog scale for pain is a straight line with one end meaning no pain and the other end meaning the worst pain imaginable.

    Time frame: Pre-operation (baseline) and then post-operation at 3-months, 6-months, and 12-months

  2. Change in the return to activities of daily living (ADL) from before surgery to after surgery

    A survey asking patients if and when patients have returned to various activities of daily living, such as work, driving, physical/recreational activities.

    Time frame: Pre-operation (baseline) and then post-operation at 3-months, 6-months, and 12-months

  3. Change in the Concomitant medications (ConMeds) from before surgery to after surgery

    A survey asking patients to indicate any medications they are taking at the time of the survey (e.g., Acetaminophen, opioids, NSAIDs, etc.)

    Time frame: Pre-operation (baseline) and then post-operation at 3-months, 6-months, and 12-months

  4. Change in the Single Assessment Numeric Evaluation (SANE) from before surgery to after surgery

    The SANE score is a validated patient reported outcome measure. It is a single question score that asks, "how would you rate your condition today as a percentage of normal (0% to 100% scale with 100% being normal)?" The SANE score is collected as standard of care.

    Time frame: Pre-operation (baseline) and then post-operation at 6-months, and 12-months

  5. Change in the American Shoulder and Elbow Surgeons Standardized Shoulder Form (ASES) from before surgery to after surgery

    The ASES is a 100-point scale that consists of two dimensions: pain and activities of daily living. There is one pain scale worth 50 points and ten activities of daily living worth 50 points

    Time frame: Pre-operation (baseline) and then post-operation at 6-months, and 12-months

  6. Change in the Constant-Murley Score from before surgery to after surgery

    The Constant-Murley Score is a multi-item functional scale assessing pain, activities of daily living, range of motion, and strength of the affected shoulder. Its score ranges from 0 to 100 points, representing worst and best shoulder function, respectively.

    Time frame: Pre-operation (baseline) and then post-operation at 6-months, and 12-months

  7. Change in the shoulder immobilization status from before surgery to after surgery

    A survey asking patients to indicate if they wore a sling after their surgery and for how long they wore their sling.

    Time frame: Post-operation at 3-months, 6-months, and 12-months

  8. Change in strength measurements from before surgery to after surgery

    Strength measurements will be collected using a handheld dynamometer while the arm is in two positions: (1) abduction with the arm in the scapular plane, and (2) external rotation while the arm is adducted and the elbow is flexed to 90 degrees

    Time frame: Pre-operation (baseline) and then post-operation at 6-months and 12-months

  9. Change in range of motion measurements from before surgery to after surgery

    Range of motion measurements will be collected using a goniometer while the arm moves through four movements: (1) forward flexion, (2) abduction, (3) external rotation, and (4) internal rotation

    Time frame: Pre-operation (baseline) and then post-operation at 6-months and 12-months

  10. Number of medical events/adverse events after surgery

    A count of the number of post-operative medical/adverse events for the affected shoulder after the patient's surgery.

    Time frame: Day of surgery and post-operation at 3-months, 6-months, and 12-months

  11. Cumulative number of steroid injections after surgery

    A count of the number of post-operative steroid injections obtained for the affected shoulder after the patient's surgery.

    Time frame: Post-operation at 3-months, 6-months, and 12-months

  12. Number of unscheduled visits after surgery

    A count of the number of clinic visits outside the typical standard of care visits for the affected shoulder after the patient's surgery.

    Time frame: Post-operation at 3-months, 6-months, and 12-months

  13. Number of for-cause imaging procedures

    A count of the number of radiographic imaging obtained, and the type of imaging obtained, for the affected shoulder after the patient's surgery.

    Time frame: Post-operation at 3-months, 6-months, and 12-months

07

Study locations

5 of 5 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06289686
Lead sponsor
Brooke Army Medical Center
Collaborators
Sparta Biopharma
Responsible party
David Tennent (Orthopaedic Surgeon, Brooke Army Medical Center) — Principal investigator
First posted
Mar 4, 2024
Start date
Jul 28, 2023
Primary completion
Aug 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Jul 13, 2026

Study contacts

David J Tennent, MD
Contact
David.J.Tennent.mil@health.mil
210-916-2048
Jonathan Dickens, MD
principal investigator · Duke University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion